Back to results
Not yet recruitingPhase 2

Mesenchymal Stromal/Stem Cells-Derived Exosomes (MSC-Exos) Therapy for Type 2 Diabetes Mellitus Patients

NCT07144241

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

UNIMUS Hospital

Semarang, Central Java, Indonesia

Contact

Dr. dr. Yanuar Ardani, M.Kes, Sp.PD, K-PPM, FINASIM

085227700340dr.yanuardani@gmail.com
View on ClinicalTrials.gov
Mesenchymal Stromal/Stem Cells-Derived Exosomes (MSC-Exos) Therapy for Type 2 Diabetes Mellitus Patients — TrialFind